BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 3311856)

  • 1. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
    Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.
    Bonora E; Bonadonna RC; Del Prato S; Gulli G; Solini A; Matsuda M; DeFronzo RA
    Diabetes; 1993 May; 42(5):764-72. PubMed ID: 8482434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women.
    Bonora E; Del Prato S; Bonadonna RC; Gulli G; Solini A; Shank ML; Ghiatas AA; Lancaster JL; Kilcoyne RF; Alyassin AM
    Diabetes; 1992 Sep; 41(9):1151-9. PubMed ID: 1499866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energy and substrate metabolism in obesity and postobese state.
    Tappy L; Felber JP; Jéquier E
    Diabetes Care; 1991 Dec; 14(12):1180-8. PubMed ID: 1773703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of weight loss on glucose disposal in obese and obese diabetic patients.
    Golay A; Felber JP; Dusmet M; Gomez F; Curchod B; Jéquier E
    Int J Obes; 1985; 9(3):181-91. PubMed ID: 3902687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus.
    Del Prato S; Bonadonna RC; Bonora E; Gulli G; Solini A; Shank M; DeFronzo RA
    J Clin Invest; 1993 Feb; 91(2):484-94. PubMed ID: 8432857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body glucose metabolism in obese patients with type 2 diabetes mellitus: the impact of hypertension and strict blood glucose control.
    Vestergaard H; Parving HH; Hansen L; Pedersen O
    Diabet Med; 1995 Feb; 12(2):156-63. PubMed ID: 7743763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
    Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
    Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein metabolism in human obesity: relationship with glucose and lipid metabolism and with visceral adipose tissue.
    Solini A; Bonora E; Bonadonna R; Castellino P; DeFronzo RA
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2552-8. PubMed ID: 9253333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic consequences of long-term human obesity.
    Felber JP; Golay A; Jéquier E; Curchod B; Temler E; DeFronzo RA; Ferrannini E
    Int J Obes; 1988; 12(5):377-89. PubMed ID: 3069764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.
    Santomauro AT; Boden G; Silva ME; Rocha DM; Santos RF; Ursich MJ; Strassmann PG; Wajchenberg BL
    Diabetes; 1999 Sep; 48(9):1836-41. PubMed ID: 10480616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
    Petrides AS; Groop LC; Riely CA; DeFronzo RA
    J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive defect of insulin action on glycogen synthase in obesity and diabetes.
    Golay A; Munger R; Assimacopoulos-Jeannet F; Bobbioni-Harsch E; Habicht F; Felber JP
    Metabolism; 2002 May; 51(5):549-53. PubMed ID: 11979384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal.
    Yokoyama H; Emoto M; Mori K; Araki T; Teramura M; Koyama H; Shoji T; Inaba M; Nishizawa Y
    J Clin Endocrinol Metab; 2006 Jan; 91(1):290-4. PubMed ID: 16234307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
    Groop LC; Bonadonna RC; DelPrato S; Ratheiser K; Zyck K; Ferrannini E; DeFronzo RA
    J Clin Invest; 1989 Jul; 84(1):205-13. PubMed ID: 2661589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose fluxes and oxidation after an oral glucose load in patients with non-insulin-dependent diabetes mellitus of variable severity.
    Féry F; Melot C; Balasse EO
    Metabolism; 1993 Apr; 42(4):522-30. PubMed ID: 8487677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents.
    Gulli G; Ferrannini E; Stern M; Haffner S; DeFronzo RA
    Diabetes; 1992 Dec; 41(12):1575-86. PubMed ID: 1446799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.